The haematocrit an impor- tant factor causing impaired haemostasis in patients with cyanotic congenital heart disease. Int J Cardiol. 2013;167:1317 21. S3.16-13. Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. I. Br Med J. 1958;2:701 9. S3.16-14. Broberg C, Ujita M, Babu-Narayan S, et al. Massive pulmonary ar- tery thrombosis with haemoptysis in adults with Eisenmenger s syn- drome: a clinical dilemma. Heart. 2004;90:e63. S3.16-15. Daliento L, Somerville J, Presbitero P, et al. Eisenmenger syn- drome. Factors relating to deterioration and death. Eur Heart J. 1998;19:1845 55. S3.16-16. Sandoval J, Santos LE, C rdova J, et al. Does anticoagulation in Eisenmenger syndrome impact long-term survival? Congenit Heart Dis. 2012;7:268 76. S3.16-17. Dedkov EI, Perloff JK, Tomanek RJ, et al. The coronary micro- circulation in cyanotic congenital heart disease. Circulation. 2006;114:196 200. S3.16-18. Duffels MGJ, Mulder KM, Trip MD, et al. Atherosclerosis in patients with cyanotic congenital heart disease. Circ J. 2010;74: 1436 41. S3.16-19. Horigome H, Hiramatsu Y, Shigeta O, et al. Overproduction of platelet microparticles in cyanotic congenital heart disease with pol- ycythemia. J Am Coll Cardiol. 2002;39:1072 7. S3.16-20. Tsui I, Shamsa K, Perloff JK, et al. Retinal vascular patterns in adults with cyanotic congenital heart disease. Semin Ophthalmol. 2009;24:262 5. S3.16-21. Dimopoulos K, Diller G-P, Koltsida E, et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation. 2008;117:2320 8. S3.16-22. Broberg CS, Van Woerkom RC, Swallow E, et al. Lung function and gas exchange in Eisenmenger syndrome and their impact on exercise capacity and survival. Int J Cardiol. 2014;171:73 7. CLINICAL STATEMENTS AND GUIDELINES S3.16-23. Broberg CS, Uebing A, Cuomo L, et al. Adult patients with Eisenmenger syndrome report flying safely on commercial airlines. Heart. 2007;93:1599 603. S3.16-24. 